Oruka

Oruka Therapeutics is a biopharmaceutical company focused on developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. The company's mission is to offer patients suffering from conditions like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with infrequent dosing. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies targeting the core mechanisms underlying dermatologic and inflammatory diseases.